Approaches | Advantages | Limitations | Nanotechnology | Joint nanotechnology | References | |
---|---|---|---|---|---|---|
Diagnosis | Endoscope | Convenient and efficient;Direct observation | Poor identification of small lesions; Strong subjectivity | SERS NPs Capsule endoscopy Confocal laser microendoscopy | Improve sensitive differentiation of small and other difficult-to-detect lesions Highly targeted | |
Tumour Markers | Convenient, high clinical value, | Limited level of expression, Susceptible to interference, Invasive | Nanobiosensors, SiNWs, SiNW-FETs, QDs | 1. Higher accuracy and sensitivity of detection 2. Easier operation 3. Noninvasive | ||
MRI | High soft tissue contrast and no ionising radiation | Nonspecific, Rapid clearance, Tissue deposition | Gd-Liposomes and Gd- nanocomplexes, SPOIN | 1, High biocompatibility 2, Highly targeted 3, Higher detection accuracy and sensitivity | ||
CT | Fast scanning time, Lower cost, High spatial resolution | Limited soft tissue identification, Low contrast accumulation | AuNPs/GNRs, AuNCs, SPOIN, WS2 nanosheets, WO2.9 nanorods | 1, Enhanced accuracy and sensitivity 2, Remarkable imaging effect 3, No toxicity 4, Multimodal imaging | ||
PET | High sensitivity and specificity; Easy to find metastatic lesions | High costs False positives in patients with inflammatory conditions | Dendritic macromolecular systems and extracellular vesicular nanoprobes | 1. Reduce false positives 2. Non-toxic 3. Highly targeted | [99] | |
Fluorescence imaging | Fast imaging, High sensitivity | With longer wavelength, the quality of tissue fluorescence and scattering decreases | ICG-Liposomes; Upconversion nanoparticles | 1. Increased diagnostic accuracy and sensitivity 2. High optical stability 3. No toxicity | ||
Treatment | Intraoperative navigation and surgery | Minimally invasive | Poor localization of tumour margins and tumours | ICG-SPION Cluster, NIRF with endoscopy, SERS/SERRS NPs | 1. Increased sensitivity and resolution at tumour margins 2. High tissue penetration | |
Chemotherapy | Good therapeutic effect | Low solubility, poor permeability, Non-specific targeting, Dose-dependent toxicity | Liposomal, Albumin, CS NPs, PLGA NPs, Nanogel, MOF | 1. Increased effectiveness of chemotherapy 2. Less toxic side effects of chemotherapy 3.Highly targeted | [151,152,153,154,155,156,157, 160,161,162,163,164,165,166,167,168,169] | |
Targeted therapy | Well-targeted and low toxic side effects | Drug resistance, Insufficient bioavailability, Insufficient controlled release | AuNPs, ND, PLGA NPs SPION/PVD; Graphene quantum dots | 1. Improving the bioavailability of delivered drugs 2. Higher targeting performance 3. Targeted controlled release | ||
Phototherapy | High temporal selectivity and low side effects and low drug resistance | Low photothermal conversion efficiency, irradiation depth and irradiation accuracy | NIRF probe bound gold nanorods and nanoporphyrin micelles; | 1. Higher photothermal conversion efficiency 2. Highly targeted 3. Combination of multiple treatment modalities | ||
Combination therapy | High treatment efficiency and Providing access to treatment for extreme malignancies | Trigger liposomes, AuNPs, Core–shell nanoparticles, Nanoporphyrin micelles; | 1、High treatment efficiency 2、providing access to treatment for extreme malignancies |